Hydronidone

DB06299InvestigationalSmall molecule

Hydronidone has antifibrotic activity.

Mechanism: Pharmacologically active on TGF-beta receptor type-1
Curator reviewed
Primary indication: Investigated for use/treatment in liver disease.Curator reviewed
Formula / weight: C₁₂H₁₁NO₂ · 201.225 g/mol (avg)
Code names: F-351

Resolves to

Compound

Structure

InChIKeyNETTXQJYJRFTFS-UHFFFAOYSA-NSMILESCC1=CN(C(=O)C=C1)C1=CC=C(O)C=C1

Targets

What you can answer from here — as of September 05, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

16Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Hydronidone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.